Package 16571-834-01

Brand: amantadine hydrochloride

Generic: amantadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 16571-834-01
Digits Only 1657183401
Product NDC 16571-834
Description

100 CAPSULE in 1 BOTTLE (16571-834-01)

Marketing

Marketing Status
Marketed Since 2022-09-05
Brand amantadine hydrochloride
Generic amantadine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1a920249-de25-4d4e-b515-4fcbf3ead399", "openfda": {"upc": ["0316571834013", "0316571834501"], "unii": ["M6Q1EO9TD0"], "rxcui": ["849389"], "spl_set_id": ["6fd54e00-a714-4442-af95-2515ab3b2ac3"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (16571-834-01)", "package_ndc": "16571-834-01", "marketing_start_date": "20220905"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (16571-834-50)", "package_ndc": "16571-834-50", "marketing_start_date": "20220905"}], "brand_name": "Amantadine Hydrochloride", "product_id": "16571-834_1a920249-de25-4d4e-b515-4fcbf3ead399", "dosage_form": "CAPSULE", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "16571-834", "generic_name": "Amantadine Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amantadine Hydrochloride", "active_ingredients": [{"name": "AMANTADINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA210129", "marketing_category": "ANDA", "marketing_start_date": "20220905", "listing_expiration_date": "20261231"}